Table 5.

Recurrence characteristics and follow-up of patients with a follow-up time of more than 2 years.

Variable	Training cohort, N =381	%	Validation cohort, N = 160	%	P value
Recurrence
No	328	86.1	134	83.7	0.482
Yes	53	13.9	26	16.3
Sites of relapse	53		26
Vaginal stump	2	3.8	2	7.7	0.902
Central pelvic region	15	28.3	7	26.9
Peritoneal metastases	12	22.6	6	23.1
Metastasis to other organs	24	45.3	11	42.3
Death
No	351	92.1	142	88.8	0.208
Death due to recurrence	26	6.8	17	10.6
Death due to other disease	4	1.1	1	0.6
RFS time (months)
Median	46.00		43.00		0.330
Mean (± SD)	44.88 (± 19.28)		43.12 (± 18.88)
Range	6-79		6-79
Follow-up (months)
Median	48.00		45.00		0.332
Mean (± SD)	47.27 (± 17.55)		45.66 (± 17.77)
Range	8-79		8-79

RFS, recurrence-free survival.